Professional Documents
Culture Documents
Pediatric Stroke
Pediatric Stroke
BY
Dr.JANAKI.AN
STROKE IN CHILDREN
“Despite efforts to raise awareness
regarding stroke in children, this condition
is often overlooked as a cause of
symptoms by health care providers and
family.”
Stroke is as common as brain tumour in
children
It is one of the 10 most commonest
causes of childhood death worldwide
2/3 of affected are left with long term
impairment
WHO definition of STROKE
• Clinical syndrome characterised by rapidly
developing signs of focal / global disturbance
of function lasting for more than 24 hours /
death with no apparent cause other than of
vascular origin
TYPES
• Perinatal stroke - 22 weeks of gestation to 1
month of postnatal age
• Childhood / pediatric stroke - 1 month of age
to 18 yrs of age
• Young stroke - in people <40 years of age
Epidemiology
Hemiplegia & hemiparesis is the most common cause of
cp in children born at term and stroke is its leading
cause.
Hemorrhagic Stroke
ARTERIAL ISCHEMIC STROKE
• It is the focal brain infarction that results from
occlusion of the cerebral arteries most
commonly MCA .
Overview of cerebral circulation
• 2 principal systems :
• anterior circulation
• Posterior circulation – vertebro basilar system
• Circle of willis – connecting these two
• Small perforating arteries that supply deeper parts
of brain – lenticulostraite vessels from ant
circulation
• thalamostriate vessels from
posterior circulation
Anterior circulation
Circle of willis
• ACA – anterio medial part of cerebral
hemisphere
• leg foot area
• putamen caudate nucleus
• anterio inferior portion of internal
capsule
• MCA – lateral part of cerebral hemisphere
• brocca, wernicke area
• face arm area of motor and sensory
cortex
• basal ganglia
• anterior and posterior superior portion of
ic
Thromboembolism
From an embolic
Local thrombus
source
Cardiogenic
Arterial (platelet rich Venous(fibrin rich Artery to artery
thrombus) thrombus) Fat
Infective vegetations
MECHANISM OF INFARCTION
• Focal brain ischemia
• Regional hypoxia and depletion energy stores
• Ischemic neuronal dysfunction – reversible
initially
• Irreversible infarction sets in
• Hypoxia
• No o2 reserve and very few glucose reserve
• Oxidative to glycolysis
• Acidosis
• Accumulation of extracellular glutamate –
• intracellular calcium
•T1 WMRI -
Rt MCA infarct
•Conventional
angiogram –
irregular
stenosis of rt
prox MCA
MOYA MOYA
SYNDROME
Large arterial ischemic
stroke of rt frontal
lobe with large vessel
&watershed lesions
b/l
Minimise recurrence
Immediate management
• Maintain airway , breathing and circulation
• Adequate supply of oxygen and metabolites
• proper oxygenation
• normoglycemia
• bp btwn 50th and 90th percentile
• Reduce metabolic demands
• control fever and seizures
• contro;l malignant cerebral edema- adequate sedation,
osmotic therapy,decompressing hemicraniectomy
• Prevent aspiration
Anticoagulation – various guidelines
• Royal College of Physician
• aspirin 5mg/kg/d- exclude SCD/ICH
• Heparin after excluding dissection and csvt
• AHA
• aspirin in children with suspected cardioembolic cause
unrelated to PFO
• UFH/LMWH as a bridge to warfarin in children with suspected
extracranial dissection severe thrombophilia, multiple emboli
• No anticoagulation in intracranial dissection
• SAH due to dissection
• ACCP American College of Chest Physicians
• Empirically start initially heparin/aspirin until
dissection and embolic cause are excluded
• Neonate – no anticoagulation / aspirin except
in recurrent stroke
• Acute mgt – aspirin 1-5 mg/kg/d
• UFH – 28u/kg/hr in infants
• 20u/kg/hr in older children
• LMWH – enoxaparin – 1mg/kg s.c
bd
• Longterm with either aspirin or warfarin
• SCD – acute – optimal hydration and exchange
transfusion
• 2ndary prevention – monthly blood
transfusion in pts with MCA BF .200m/s by
TCD
• Moyamoya – revascularisation surgeries
rehabilitation
• Physiotherapy
• CIMT- constraint induced movement therapy
• Transcranial magnetic stimulation
• Spasticity interventions- botulinium toxin
• anklefoot orthoses
• lycra hand spilnts
• Occupational therapy
• Psychological family support
• Treatment of complications – epilepsy- AED
• hyperkinetic movt disorders-anticholinergic and
antidopamine drugs
• headache – acetaminophen , cautious nsaid,
flunarizine
CEREBRAL SINOVENOUS
THROMBOSIS
CSVT
• Thrombosis in the cerebral venous sytem
• Risk highest in neonates and males
• Involves superficial venous system commonly
– causing b/l parasagittal infarcts especially
with hemorrhagic transformation
• Deep venous thrombosis causes venous
edema & infarction of deep white matter ,
basal ganglia and thalamus – with risk of ivh
Blood coagulation
Risk factors
PROTHROMBOTIC CONDITIONS
-Factor v leiden
-Protein c protein s deficiency
-ELev lipoprotein a
-Antiphospholipid antibody
-Prothrombin20210A mutation
DEHYDRATION
IEM
NEPHROTIC SYNDROME
BLOOD VESSEL INFECTION & THROMBOPHLEBITIS
-OM, mastoiditis, bact meningitis,
sinusitis, pharyngitis,
-lemieeres syndrome
-Sepsis
TRAUMA
COMPRESSION
-at birth,
-Occipital bone in supine neonate
IATROGENIC
-neurosurgery
-catheterization
VASCULAR
Dural av fistula
MECHANISM OF INFARCTION
• Venous sinus thrombosis
• Failure of venous emptying
• Rise in venous pressure
• Parenchymal vasogenic edema without true
infarction,accompanied by focal clinical symptoms
• With further increse in tissue pressure exceeding incoming
arterial perfusion pressure – perm infarction occurs
Hemorrhage in gradient
echo
TREATMENT OF CSVT
• CSVT WITHOUT ICH
• Antithrombotic treatment is reccomended in all
guidelines
• RCP – anticoagulation until recanalisation /upto 6
months after thrombosis
• ACCP/AHA – initial UFH/LMWH Until
recanalisation or until 3 to 6 months. IF NO
IMPROVEMENT – thrombectomy / surgical
decompression
• CSVT WITH ICH
• ACCP – no initial anticoagulation – repeat
imaging after 5-7 days , if thrombosis has
progressed – anticoagulation
• AHA – UFH / L;MWH bridging to warfarin upto
3 – 6 months
OTHER MANAGEMENT
• MANAGEMENT OF RISED ICT
• Malignant ict and ischemic optic neuropathy is a dreaded
complication
• Occurs secondary to thrombosis, narrow venous sinuses, or
communicating hydrocephalus
• Global impaired venous drainage are at increased risk
• regular fundoscopy & serial visual field testing
• Treatment – carbonic anhydrase inhibitors
• Serial lumbar punctures
• Optic nerve sheath fenestration
• Lumboperitoneal shunting
• Septic csvt – antigen specific antibiotics
• Mastoiditis – surgical mastoidectomy
• Removing jugular venous lines
• Altering the chemotherpy
• Replacing depleted anticoagulation factors
• Ensuring full hydration
• Replacing iron stores
• DECOMPRESSIVE HEMICRANIECTOMY
COMPLICTIONS
• Persistent rised ICT
• Communicating hydrocephalus
• Visual sequelae
• Epilepsy
• Incomplete recanalisation
• Recurrence 13 %
HEMORRHAGIC STROKE
HEMORRHAGIC STROKE
Occurs when cerebral blood vessels rupture
A neurological emergency – high mortality rate –
aacutely & secondory to high reccurence rate
TYPES SITE
• Abn bld vessels • ICH(75%)
• ( vasc malf)
• SAH(25%)
• Normal bld vessels
• (Bleeding diathesis) • IVH mc in neonates/ or due
to extension from ICH/SAH
ISCHEMIC STROKE HS
• Specific cause less likely • Specific cause more likely
• ---- • Definite treatment often
neurosurgerical intervention
• More mortality
• Less mortality • Better neurological outcome
in survivors
• Poor neurological outcome
in survivors
• ---- • Long term recurrence rate is
quite high
PATHOPHYSIOLOGY
IPH
• Rupture of arteries
• - larger arteries in congenital aneurysms
• -medium arteries in AVM
• -distal small arteries in mycotic aneurysms
• Intraparenchymal hematoma – disrupt neuronal
structures by – mech means & by compromising
perfusion
• Presence of bld products & damage to BBB- cerebral
edema – neurological deficits, seizures, malignant ICT
SAH
• Larger prox cerebral arteries within CSF in the
subarachnoid space
• Ruptures and spills blood directly into SAH
• Extend in to brain parenchyma
• RISK OF ISCHEMIC STROKE
• RISK OF HYDROCEPHALUS – communicating /
obstructive
Clinical features
• Instantaneous severe headache – hallmark of HS - >50%
• But subtle slowly progressive presentations also
common
• Asso with nausea vomitting neck stiffness
• Altered consciousness
• Focal neurological deficit based on site of bleed
• high BP
• Unexplained irritability, behavioural changes , bulging
fontanel may be the presentation in young infants
• Vein of Galen malformation presents with ccf and
macrocephaly
NEUROIMAGING
• CT brain - high sensitivity 92 – 100% in first 24-48hrs
• CTA – spot sign – contrast enhancement within the
primary ICH – site of active dynamic hemorrhage-
predicts early hematoma &hematoma growth
• MRI – Gradient echo, susceptibiliy weighted – detect
extremely small microbleeds
• CA – gold standard in childhood HS
• Done to define the complete characteristics of vascular
pathology and when interventional procedure is also
planned
AV MALFORMATION
Contrast CT –
enhancement of rt
frontal mass
T1 w MRI – multiple
flow voids
FLOW SENSITIVE
SEQUENCE – shows
flow in abn bld vessels
in AVM
SACCULAR ANEURYSM OF
LT ANT CEREBRAL ARTERY
CT
CT SPIRAL ANGIOGRAPHY
CONVENTIONAL ANGIOGRAPHY
Risk factors
VASCULAR CONGENITAL
-AVM
-cavernous malformation
-venous angiomas
-Aneurysm - primary, osler weber rendu
synrome
-PHACES
-COL4A1
-FMD
ACQUIRED
-Trauma
-brain tumors
-Arteriopathy – moyamoya, SCD, arterial
dissection , vasculities, post radiation,
-DAVF
-infection- bacterial endocarditis, HIV
Vasculopathy, bacterial meningitis
INTRAVASCULAR / SYSTEMIC COAGULOPATHY
-DIC
-hemophilia
-hematological malignancy
THROMBOCYTOPENIA
-ITP
-TTP
-HUS
HYPERTENSION
IATROGENIC
MEDICATIONS – thrombolytics,
anticoagulants, antiplateletdrugs
treatment
• NEUROSURGICAL INTERVENTION is required in
60 – 80 %of cases
• Intraventricular drains
• Clipping / coiling of aneurysms
• Removal / emblisation of AVM
• Ventriculoperitoneal shunts
• Revascularsation in moyamoya
Medical Management Of Underlying
Condition
• Antibiotics for infection
• Replacement of deficient factors
• Reversal of offending drugs
• Immunomodulatory therpy
Outcome
• Blom et al., - 65 % survival rate, 50% favourable outcome